Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Fulgent Genetics Inc
(NQ:
FLGT
)
22.56
-0.56 (-2.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
135,019
Open
23.10
Bid (Size)
22.14 (1)
Ask (Size)
22.93 (1)
Prev. Close
23.12
Today's Range
22.16 - 23.10
52wk Range
18.91 - 33.28
Shares Outstanding
29,926,846
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Fulgent Reports Second Quarter 2024 Financial Results
August 02, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024
July 11, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Performance
YTD
-22.98%
-22.98%
1 Month
-4.29%
-4.29%
3 Month
+8.10%
+8.10%
6 Month
-4.97%
-4.97%
1 Year
-30.84%
-30.84%
More News
Read More
Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer
June 03, 2024
From
Fulgent Pharma
Via
Business Wire
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
May 24, 2024
From
Fulgent Pharma
Via
Business Wire
Earnings Preview: Fulgent Genetics
November 02, 2023
Via
Benzinga
Why Is Fulgent Genetics Stock Moving Higher Today?
August 04, 2023
Via
Benzinga
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
May 14, 2024
From
Fulgent Pharma
Via
Business Wire
FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024
May 03, 2024
Via
InvestorPlace
Fulgent Reports First Quarter 2024 Financial Results
May 03, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
April 11, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Earnings Outlook For Fulgent Genetics
August 03, 2023
Via
Benzinga
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
February 13, 2024
From
Fulgent Genetics, Inc.
Via
Business Wire
The 3 Best Digital Health Stocks for Personalized Medicine
November 25, 2023
Via
InvestorPlace
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 14, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
November 03, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Earnings Scheduled For November 3, 2023
November 03, 2023
Via
Benzinga
Fulgent Reports Third Quarter 2023 Financial Results
November 03, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
October 25, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023
October 17, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2023
Via
Benzinga
Fulgent Reports Second Quarter 2023 Financial Results
August 04, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Earnings Scheduled For August 4, 2023
August 04, 2023
Via
Benzinga
Exagen Inc. Appoints Paul Kim to Board of Directors
July 24, 2023
From
Exagen Inc.
Via
GlobeNewswire
Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023
July 18, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.